Seongnam, South Korea

Eu Ddeum Chung

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kanaph Therapeutics Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **The Innovative Contributions of Eu Ddeum Chung in Pharmaceutical Research**

Introduction

Eu Ddeum Chung is an accomplished inventor based in Seongnam-si, South Korea. With a focus on pharmaceutical innovations, Chung has made significant contributions to the field, particularly in the development of inhibitors that target critical biological pathways. His work promises to advance therapeutic strategies for various diseases.

Latest Patents

Chung holds one notable patent titled "SHP2 inhibitor and use thereof." This patent pertains to the invention of an inhibitor of SHP2, coupled with a pharmaceutical composition aimed at preventing or treating diseases associated with SHP2. The patent describes effective methods for using this inhibitor to combat health issues linked to SHP2 dysfunctions. Chung's innovation stands out for its potential to offer new treatment avenues in the medical field.

Career Highlights

Chung is associated with Kanaph Therapeutics Inc., where he leverages his expertise in pharmaceutical sciences to drive innovation. His career reflects a strong commitment to research and development, leading to advancements that address unmet medical needs. The focus on SHP2 inhibitors illustrates his ability to tackle complex biological challenges through inventive solutions.

Collaborations

In his endeavors, Chung collaborates with notable colleagues, including Miyeon Kim and Dohyun Park. These partnerships are vital for fostering a creative research environment, which enhances the development of effective therapeutics. Their combined expertise contributes to robust scientific inquiry and innovation within the pharmaceutical landscape.

Conclusion

Eu Ddeum Chung exemplifies the dynamic nature of modern inventorship in the pharmaceutical sector. His innovative work on SHP2 inhibitors not only paves the way for new treatment modalities but also showcases the importance of collaboration in scientific research. As Chung continues to develop groundbreaking solutions, he remains a pivotal figure in the ongoing quest for effective disease prevention and treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…